GlassScriptPhysician profile
Christopher Cklamovski
NPI 1528563483
$7,367.57
in general payments reported to CMS, 2019-2025
17 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2021: $38.73 · 2022: $3,408 · 2023: $1,697 · 2024: $1,412 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,987 · Travel and Lodging: $711 · Education: $77.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,986.57 |
| Travel and Lodging | $710.78 |
| Education | $77.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,965.70 | 2021-2024 | Prostep, Prophecy, Ortholoc 2 Lapifuse |
| Medwest Associates | $1,200.00 | 2022 | |
| Organogenesis INC. | $1,019.71 | 2022-2024 | Puraply, Puraply Wound Matrix, Affinity |
| Kerecis Limited | $649.84 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $559.90 | 2023-2025 | Grafix Pl, Stravix, Stravix Pl |
| Treace Medical Concepts, INC. | $526.71 | 2023-2025 | |
| Medical Device Business Services, INC. | $360.00 | 2022 | |
| Horizon Therapeutics Plc | $278.22 | 2022-2023 | Krystexxa |
| Mimedx Group, INC. | $269.34 | 2024-2025 | |
| Paragon 28, INC. | $145.11 | 2019 | |
| Paratek Pharmaceuticals, INC. | $144.67 | 2022-2023 | Nuzyra |
| Cardiovascular Systems INC. | $90.92 | 2022 | |
| Surgenex LLC | $60.20 | 2025 | Renograft, Surgraft, Pellograft |
| Collaborative Care Diagnostics, LLC | $47.99 | 2022 | |
| Aroa Biosurgery Incorporated | $21.24 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $15.57 | 2023 | Surgx, Xperience, Blastx |
| Polynovo North America LLC | $12.45 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cklamovski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.